Focused Alpha’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$673K Sell
27,898
-4,239
-13% -$102K 0.17% 112
2026
Q2
$778K Sell
32,137
-1,983
-6% -$48K 0.2% 99
2026
Q1
$827K Buy
34,120
+467
+1% +$11.3K 0.26% 85
2025
Q4
$817K Buy
+33,653
New +$818K 0.24% 82

Other funds holding IBDS

Focused Alpha's IBDS Position: Q3 2026 in Review

Focused Alpha reduced its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 13% in Q3 2026, selling an estimated $102K and leaving 27,898 shares worth $673K. The position accounts for 0.17% of the portfolio, ranked #112.

Focused Alpha first reported a position in IBDS in Q4 2025 and has held it in 4 quarters since. The position peaked at $827K in Q1 2026. 414 funds tracked by Wall St. Rank hold IBDS as of Q3 2026.

  • Focused Alpha held 27,898 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $673K as of Q3 2026.
  • Focused Alpha sold 4,239 iShares iBonds Dec 2027 Term Corporate ETF shares in Q3 2026, an estimated $102K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.17% of Focused Alpha's portfolio in Q3 2026, its #112 holding.
  • Focused Alpha first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q4 2025 and has held it in 4 quarters since.
  • Focused Alpha's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $827K in Q1 2026.
  • 414 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q3 2026.

Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.